Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Clinical trial NCT07400003 · RECRUITING
Trial details
- NCT number
- NCT07400003
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-06
- Primary completion
- 2026-05-31
- Enrollment
- 519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.